Table 4.
Tendon rupture | Exposed cases/total | Exposed controls/total | Adjusted IRR | Adjusted p value |
---|---|---|---|---|
Any tendon rupture | ||||
Oral corticosteroid alone | 287/4836 | 443/18,356 | 2.58 (2.19–3.03) | < 0.001 |
Oral corticosteroid plus fluoroquinolone exposure | 36/4836 | 20/18,356 | 6.88 (3.93–12.03) | < 0.001 |
Achilles tendon rupture | ||||
Oral corticosteroid alone | 148/1557 | 180/6007 | 4.59 (3.43–6.14) | < 0.001 |
Oral corticosteroid plus fluoroquinolone exposure | 37/1557 | 10/6007 | 19.36 (7.78–48.19) | < 0.001 |
Adjusted for exact age, body mass index, Charlson co-morbidity score, hypothyroidism, hyperthyroidism, injectable corticosteroid therapy, smoking status, statin therapy and prior history of tendon rupture
IRR incidence rate ratio